Alpha 1 Global

Our mission is to develop a collaborative global network of Alpha-1 patient leaders, physicians, and researchers, to increase awareness, detection, and access to care for Alphas around the world.


European Lung Foundation Conducts Alpha-1 Survey to Establish Future Research Priorities

The European Lung Foundation (ELF) is asking members of the Alpha-1 community for their help in identifying the challenges of care, treatment and living with …

Read More

Alpha-1 Global Announces Launch of Alpha-1 Global Hub Centers

Alpha-1 Global is launching a program called the Alpha-1 Global Hub Centers. The goal of the program is to create 5-6 centers globally that will …

Read More

CSL Behring Announces Grant for EU Advocacy Development

Dear EU Alpha-1 Global Partners: We are pleased to provide you information regarding CSL Behring’s announcement for Local Empowerment for Advocacy Development (LEAD) Grants available …

Read More

CSL Behring announcement on their product Zemaira

Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin …

Read More

Alpha-1 Global mourns the loss of Guillermo Menga, MD

It is with a heavy heart that the Alpha-1 Global program, at the Alpha-1 Foundation, announces the passing of Guillermo Menga, MD, director of the …

Read More

Karen, living with Alpha-1 Antitrypsin Deficiency (Alpha-1)

I am Karen, and I am 46 years old and an elite disabled athlete. Because of my plasma therapy, I can participate in sports, run …

Read More

4th International Research Conference on Alpha-1 Antitrypsin & 7th Alpha-1 Global Patient Congress

The Alpha-1 Foundation hosted the 4th International Research Conference and the 7th Global Patient Congress, April 3-6, 2019, in Dubrovnik, Croatia. The Patient Congress was …

Read More

Respreeza announcement for Europe

Patients in Europe (Respreeza®) might experience a disruption of Respreeza® in the coming days. Respreeza® is CSL Behring’s prescription drug for the treatment of Alpha-1 …

Read More

Alfa1 Espana Receives “Best 2018 Respiratory Patient Project”

A hearty “Congratulations” to Alfa 1 España  for “Alfas en Camino” being selected as the Best 2018 Respiratory Patient Project by Separ De Pacientes Respiratorios! …

Read More

Grifols Affirms Commitment to Patients During Alpha-1 Awareness Month

November is Alpha-1 Awareness Month, and Grifols is proud to share its efforts to further increase Alpha-1 diagnosis rates and expand treatment options. Alpha-1 awareness matters. …

Read More

Alpha-1 Around The Globe

Click on the country flags below to learn more about country specific contact and general information, access to care, and available resources

Join Our Newsletter

Subscribe to stay in touch with the latest in Alpha-1 Global